BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1531835)

  • 1. Targeted enhancement of the biological activity of the antineoplastic agent, neocarzinostatin. Studies in murine neuroblastoma cells.
    Schor NF
    J Clin Invest; 1992 Mar; 89(3):774-81. PubMed ID: 1531835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A neurologist's approach to neuroblastoma.
    Schor NF
    J Child Neurol; 1992 Jan; 7(1):93-8. PubMed ID: 1313058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neocarzinostatin induces neuronal morphology of mouse neuroblastoma in culture.
    Schor NF
    J Pharmacol Exp Ther; 1989 Jun; 249(3):906-10. PubMed ID: 2525186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroblastoma: a neurochemical approach.
    Schor NF
    J Child Neurol; 1991 Jul; 6(3):220-8. PubMed ID: 1651966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin.
    Hartsell TL; Yalowich JC; Ritke MK; Martinez AJ; Schor NF
    J Pharmacol Exp Ther; 1995 Oct; 275(1):479-85. PubMed ID: 7562588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal 'differentiation' of murine neuroblastoma cells induced by neocarzinostatin: neural cell adhesion molecules.
    Lowengrub JA; Schor NF
    Brain Res; 1993 Jun; 613(1):123-31. PubMed ID: 8348295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of neocarzinostatin-induced cell death and morphologic change in SK-N-SH human neuroblastoma cells by continuous exposure to nerve growth factor.
    Falcione M; Milligan KD; Schwartz MC; Schor NF
    Biochem Pharmacol; 1993 Aug; 46(4):731-8. PubMed ID: 8363646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neocarzinostatin upon the development of tumors from murine neuroblastoma cells.
    Will P; Guger KA; Schor NF
    Cancer Chemother Pharmacol; 1994; 35(2):115-20. PubMed ID: 7987986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy.
    Rogers D; Nylander KD; Mi Z; Hu T; Schor NF
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):699-706. PubMed ID: 18338171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells.
    Tatsumi K; Tashima M; Shirakawa S; Nakamura T; Uchino H
    Cancer Res; 1979 May; 39(5):1623-7. PubMed ID: 154973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2-mediated potentiation of neocarzinostatin-induced apoptosis: requirement for caspase-3, sulfhydryl groups, and cleavable Bcl-2.
    Mi Z; Hong B; Mirnics ZK; Tyurina YY; Kagan VE; Liang Y; Schor NF
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):357-67. PubMed ID: 16001169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells.
    Lai CT; Yu PH
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):186-91. PubMed ID: 9007048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of mitotic arrest and protein synthesis in induction of apoptosis and differentiation in neuroblastoma cells in culture.
    Smith TK; Nylander KD; Schor NF
    Brain Res Dev Brain Res; 1998 Feb; 105(2):175-80. PubMed ID: 9541736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiols screened by the neocarzinostatin protein for preserving or detoxifying its bound enediyne antibiotic.
    Chi HW; Huang CC; Chin DH
    Chemistry; 2012 May; 18(20):6238-49. PubMed ID: 22473745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delocalized electronic structure of the thiol sulfur substantially prevents nucleic acid damage induced by neocarzinostatin.
    Kuo HM; Lee Chao PD; Chin DH
    Biochemistry; 2002 Jan; 41(3):897-905. PubMed ID: 11790112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of the response of neuroblastoma cells to DNA damage: the roles of pre-treatment cell morphology and chemical nature of the damage.
    Hartsell TL; Hinman LM; Hamann PR; Schor NF
    J Pharmacol Exp Ther; 1996 May; 277(2):1158-66. PubMed ID: 8627528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine potentiation on lethality of L-1210 cells treated with neocarzinostatin.
    Sasada M; Sawada H; Nakamura T; Uchino H
    Gan; 1976 Jun; 67(3):447-9. PubMed ID: 137161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neocarzinostatin: molecular mechanism of action and prospects for clinical use].
    Köhnlein W; Jung G
    Arzneimittelforschung; 1982; 32(11):1474-9. PubMed ID: 6217819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of dopamine to mouse neuroblastoma x rat glioma hybrid (NG108) cells in vitro.
    Wang RG; Zhu XZ
    Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):294-6. PubMed ID: 7668093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive use of ethiofos (WR-2721) with free radical-generating chemotherapeutic agents in mice: new caveats for therapy.
    Tabachnik Schor NF
    Cancer Res; 1987 Oct; 47(20):5411-4. PubMed ID: 2820568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.